Ads
related to: Sanofi- What You Need to Know
Learn the Risk Factors of T1D.
Take the Type 1 Risk Quiz
- Screen Early for T1D
Learn the Importance of
Screening Early
- T1D Risk Factors
Take the Type 1 Risk Quiz to
Understand Your Risk for T1D
- Doctor Discussion Guide
Download the Doctor Discussion
Guide for More on Screening & T1D.
- What You Need to Know
Search results
EU approves Sanofi's Dupixent for 'smoker's lungs'
Reuters via Yahoo Finance Canada· 5 days agoThe EU Commission approved Dupixent to treat chronic obstructive pulmonary disease (COPD) in patients that cannot be helped by standard inhaled drugs, ...
Sanofi eyes German insulin investment of up to $1.6 billion, source says
Reuters via Yahoo Finance Canada· 7 days agoFrench drugmaker Sanofi is nearing a decision to invest between 1.3 billion and 1.5 billion euros...
Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
Bloomberg via Yahoo Finance Canada· 4 days ago(Bloomberg) -- Private equity firms Bain Capital and Cinven are exploring a potential joint bid for...
Bpifrance eyes investment in Sanofi's consumer health business
Reuters via Yahoo Finance Canada· 3 days agoThe French public investment bank is in talks with "many funds" and may team up with the winning bidder for Sanofi's consumer health unit, Gonzalo was quoted as saying. Bpifrance ...
French State Investment Firm Eyes Stake in Sanofi Consumer Unit
Bloomberg via Yahoo Finance Canada· 4 days ago(Bloomberg) -- Bpifrance SACA is looking at a potential investment in Sanofi SA’s consumer health...
Sanofi Blockbuster Wins Clearance in Europe for Lung Disease
Bloomberg· 5 days agoSanofi’s Dupixent was cleared for a chronic lung disorder in the European Union, creating another...
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Zacks via Yahoo Finance Canada· 4 days agoRegeneron (REGN) and partner Sanofi get approval for their blockbuster drug Dupixent for the chronic...
EU approves Sanofi drug for chronic lung disease
Medical Xpress· 4 days agoThe European Union has approved Sanofi and Regeneron's blockbuster drug Dupixent for the treatment of chronic obstructive pulmonary disease (COPD), the...
Sanofi CEO on AI's Impact, Lung Disease Drug Clearance
Bloomberg· 4 days agoSanofi CEO Paul Hudson joins Caroline Hyde to discuss the company's integration of AI tools in...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance Canada· 2 days agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...